在芬太尼兴奋剂组合的驱使下,65岁以上成年人的芬太尼死亡率从2015年的9.9%上升到2023年的99%。 Fentanyl deaths in adults 65+ rose 9,000% from 2015 to 2023, driven by fentanyl-stimulant combos.

2015年至2023年,65岁及65岁以上成年人与芬太尼有关的死亡上升了9.9%,根据在2025年ANESHESIOLOGY提交的一项研究分析的疾病防治中心数据,芬太尼兴奋剂混合物目前造成近一半的此类死亡。 Fentanyl-related deaths among adults 65 and older have surged 9,000% from 2015 to 2023, with fentanyl-stimulant combinations now responsible for nearly half of such deaths, according to CDC data analyzed in a study presented at ANESTHESIOLOGY 2025. 可卡因和甲基安非他明使用造成的上升反映出阿片第四波流行对老年人的影响越来越大,尽管老年人的药物新陈代谢速度较慢,慢性病发病率也较高。 The rise, driven by cocaine and methamphetamine use, reflects a growing impact of the fourth wave of the opioid epidemic on older adults, despite their slower drug metabolism and higher rates of chronic conditions. 研究人员强调,保健提供者需要筛查多种药物的使用,减少类阿片处方,提供非类阿片替代品,扩大减少伤害的努力,如向这一弱势群体提供纳洛酮和简化药物常规。 Researchers stress the need for healthcare providers to screen for polysubstance use, reduce opioid prescriptions, offer non-opioid alternatives, and expand harm-reduction efforts like naloxone access and simplified medication routines for this vulnerable group.